China Says Homegrown mRNA Covid Shot Is Preferred Booster

(Bloomberg) — China said its recently-approved first homegrown mRNA Covid vaccine was one of its two preferred boosters, potentially encouraging more people to get their follow-up shots amid a renewed government campaign to shore up immunity.

The messenger RNA vaccine developed by CSPC Pharmaceutical Group Ltd., which targets the omicron variant — along with another new shot created by Beijing-based drugmaker Sinocelltech Group Ltd. targeting four variants, including omicron — should be the preferred booster immunizations for adults, according to a statement issued by the National Health Commission late Monday.